newsfilter
← Latest News
GlobeNewswire·

MacroGenics to Participate in Upcoming Investor Conference

ROCKVILLE, MD, Dec. 02, 2024 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative monoclonal